References
  1. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000 Aug 17;343(7):481-92. doi: 10.1056/NEJM200008173430707. PMID: 10944566.
  2. Hoover K, Higginbotham K. Epstein Barr Virus. 2020 Nov 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. PMID: 32644711.
  3. Kimura H, Cohen JI. Chronic Active Epstein-Barr Virus Disease. Front Immunol. 2017 Dec 22;8:1867. doi: 10.3389/fimmu.2017.01867. PMID: 29375552; PMCID: PMC5770746.
  4. Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005 Sep;80(1):64-9. doi: 10.1002/ajh.20398. PMID: 16138335.
  5. Kimura H, Cohen JI. Chronic Active Epstein-Barr Virus Disease. Front Immunol. 2017 Dec 22;8:1867. doi: 10.3389/fimmu.2017.01867. PMID: 29375552; PMCID: PMC5770746.
  6. Roth DE, Jones A, Smith L, Lai R, Preiksaitis J, Robinson J. Severe chronic active Epstein-Barr virus infection mimicking steroid-dependent inflammatory bowel disease. Pediatr Infect Dis J. 2005 Mar;24(3):261-4. doi: 10.1097/01.inf.0000154335.48682.af. PMID: 15750464.
  7. Yang XZ, Zheng JM, Li RK, Wu SL, Yang QL, Luo ZG, Du ZG, Sang LY, Zhang WH. [Three cases of chronic active EBV infection associated enteritis]. Chinese Journal of Infectious Diseases2020,38(6):371-373. DOI:10.3760/cma.j.cn311365-20190814-00262. 1
  8. Zhang B, Wang X, Tian X, Cai Y, Wu X. Chronic Active Epstein-Barr Virus-Associated Enteritis: CT Findings and Clinical Manifestation. Biomed Res Int. 2020 Jun 22;2020:2978410. doi: 10.1155/2020/2978410. PMID: 32685462; PMCID: PMC7327557. 2
  9. Dong XY, Li J, Li Y, Wu D, Zhang Y, Cao W, Zhou WX, Yang H, Qian JM. [The clinical characteristics of immunocompetent adults with chronic active Epstein-Barr virus associated enteritis]. Zhonghua Nei Ke Za Zhi. 2018 Jul 1;57(7):487-493. Chinese. doi: 10.3760/cma.j.issn.0578-1426.2018.07.004. PMID: 29996266. 4
  10. Liu R, Wang M, Zhang L, Zhou W, Huang Y, Guo H, Gu Y, Chen Y, Li Y, Chen C, Wang Y, Rong L, Li J, Xu J, Cao Q, Jiang Z. The clinicopathologic features of chronic active Epstein-Barr virus infective enteritis. Mod Pathol. 2019 Mar;32(3):387-395. doi: 10.1038/s41379-018-0144-1. Epub 2018 Oct 8. PMID: 30297882. 6
  11. Zhang Y, Jiang Z, Liu R, Chen H, Wang M, Cao Q. Chronic Active Epstein-Barr Virus Associated Enteritis May Develop into a Precancerous Disease. Inflamm Bowel Dis. 2017 May;23(5):E19-E21. doi: 10.1097/MIB.0000000000001092. PMID: 28394808. 7
  12. Lavín AC, Román JG, Zárate SA, Porras MC, Caviedes JR. Acute upper gastrointestinal bleeding associated with Epstein-Barr virus reactivation in an immunocompetent patient. Am J Gastroenterol. 2009 Jan;104(1):253-4. doi: 10.1038/ajg.2008.25. PMID: 19098888. 14
  13. Shi W, Jiang ZN. [Chronic active Epstein-Barr virus enteritis: report of a case]. Zhonghua Bing Li Xue Za Zhi. 2016,45(10):725-726. DOI:10.3760/cma.j.issn.0529-5807.2016.10.016. 15
  14. Tashiro Y, Goto M, Takemoto Y, Sato E, Shirahama H, Utsunomiya A, Eizuru Y, Yonezawa S. Epstein-Barr virus-associated enteritis with multiple ulcers after stem cell transplantation: first histologically confirmed case. Pathol Int. 2006 Sep;56(9):530-7. doi: 10.1111/j.1440-1827.2006.02001.x. PMID: 16930333.
  15. Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33:787-821. doi: 10.1146/annurev-immunol-032414-112326. Epub 2015 Feb 11. PMID: 25706097.
  16. Digestive pathology collaborative group, division of Gastroenterology, Chinese Medical Association,Ye ZY,Xiao SY,Zhang JM,Shi XY,Zheng LR,Wang X,Tian SF,Huang Y,Li ZS.[Consensus on tissue testing and pathologic diagnosis of intestinal Epstein Barr virus infection].Chinese Journal of Digestion.2019,39(7):433-437. DOI:10.3760/cma.j.issn.0254-1432.2019.07.001.
  17. Karlitz JJ, Li ST, Holman RP, Rice MC. EBV-associated colitis mimicking IBD in an immunocompetent individual. Nat Rev Gastroenterol Hepatol. 2011 Jan;8(1):50-4. doi: 10.1038/nrgastro.2010.192. Epub 2010 Nov 30. PMID: 21119609.
  18. Sairenji T, Collins KL, Evans DV. An Update on Inflammatory Bowel Disease. Prim Care. 2017 Dec;44(4):673-692. doi: 10.1016/j.pop.2017.07.010. Epub 2017 Oct 5. PMID: 29132528.
  19. Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, Peyrin-Biroulet L, Cullen GJ, Daperno M, Kucharzik T, Rieder F, Almer S, Armuzzi A, Harbord M, Langhorst J, Sans M, Chowers Y, Fiorino G, Juillerat P, Mantzaris GJ, Rizzello F, Vavricka S, Gionchetti P; ECCO. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis. 2017 Jan;11(1):3-25. doi: 10.1093/ecco-jcc/jjw168. Epub 2016 Sep 22. PMID: 27660341.
  20. Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011 Jun 2;117(22):5835-49. doi: 10.1182/blood-2010-11-316745. Epub 2011 Mar 31. PMID: 21454450; PMCID: PMC3112034.
  21. Sawada A, Inoue M, Kawa K. How we treat chronic active Epstein-Barr virus infection. Int J Hematol. 2017 Apr;105(4):406-418. doi: 10.1007/s12185-017-2192-6. Epub 2017 Feb 16. PMID: 28210942.
  22. Xu L, Ba H, Lin H, Zhong L, Li S, Tang W, Ke Z, Ye Z. A new therapy in Epstein-Barr virus-associated lymphoproliferative disease: a case report and a revision of the literature. Ital J Pediatr. 2019 Nov 4;45(1):135. doi: 10.1186/s13052-019-0741-8. PMID: 31685000; PMCID: PMC6827238.
  23. Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol. 2009 Sep;20(9):1472-1482. doi: 10.1093/annonc/mdp064. Epub 2009 Jun 10. PMID: 19515747; PMCID: PMC2731018.
  24. Wang Y, Li Y, Meng X, Duan X, Wang M, Chen W, Tang T, Li Y. Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disorder Presenting as Chronic Diarrhea and Intestinal Bleeding: A Case Report. Front Immunol. 2018 Nov 16;9:2583. doi: 10.3389/fimmu.2018.02583. PMID: 30519236; PMCID: PMC6251325.
  25. Chen H, Zhang Y, Jiang Z, Zhou W, Cao Q. A Case Report of NK-Cell Lymphoproliferative Disease With a Wide Involvement of Digestive Tract Develop Into Epstein-Barr Virus Associated NK/T Cell Lymphoma in an Immunocompetent Patient. Medicine (Baltimore). 2016 Mar;95(12):e3176. doi: 10.1097/MD.0000000000003176. PMID: 27015206; PMCID: PMC4998401.
  26. Zheng X, Xie J, Zhou X. Epstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report. Int J Clin Exp Pathol. 2015 Jul 1;8(7):8598-602. PMID: 26339440; PMCID: PMC4555768.
  27. Na HK, Ye BD, Yang SK, Yang DH, Jung KW, Kim KJ, Byeon JS, Myung SJ, Huh J, Kim JH. EBV-associated lymphoproliferative disorders misdiagnosed as Crohn’s disease. J Crohns Colitis. 2013 Sep;7(8):649-52. doi: 10.1016/j.crohns.2012.09.018. Epub 2012 Oct 15. PMID: 23078910.
Table 1 Clinical and colonoscopic manifestations of the case